Feedback / Questions
Romet (repirinast) - Algernon Pharma
https://www.globenewswire.com/news-release/2022/04/26/2428910/0/en/Algernon-Pharmaceuticals-Announces-Lead-Chronic-Kidney-Disease-Drug-Repirinast-Reduced-Fibrosis-by-56-in-a-Preclinical-NASH-Study.html
Apr 27, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next